IMPL
Price:
$0.04
Market Cap:
$956.00K
Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The company is also developing INP105, an upper nasal formulation of olanzapine for the acute treatment of agitation and aggression in autism spectrum disorder; and INP107, an upper nasal formulation of carbidopa/levodopa, which has completed Phase IIa clinical trial for the treatment of OFF episodes in Parkinson's disease. Impel Pharmaceuticals Inc. was f...[Read more]
Industry
Biotechnology
IPO Date
2021-04-23
Stock Exchange
NASDAQ
Ticker
IMPL
According to Impel Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -8512000.00. This represents a change of -110.57% compared to the average of 80.55M of the last 4 quarters.
The mean historical Enterprise Value of Impel Pharmaceuticals Inc. over the last ten years is 126.04M. The current -8512000.00 Enterprise Value has changed -775.32% with respect to the historical average. Over the past ten years (40 quarters), IMPL's Enterprise Value was at its highest in in the March 2021 quarter at 303.75M. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.
Average
126.04M
Median
119.27M
Minimum
67.24M
Maximum
198.40M
Discovering the peaks and valleys of Impel Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 23.94%
Maximum Annual Enterprise Value = 198.40M
Minimum Annual Increase = -66.11%
Minimum Annual Enterprise Value = 67.24M
| Year | Enterprise Value | Change |
|---|---|---|
| 2022 | 78.45M | 16.68% |
| 2021 | 67.24M | -66.11% |
| 2020 | 198.40M | 23.94% |
The current Enterprise Value of Impel Pharmaceuticals Inc. (IMPL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
114.70M
5-year avg
126.04M
10-year avg
126.04M
Impel Pharmaceuticals Inc.’s Enterprise Value is greater than InVivo Therapeutics Holdings Corporation (-14406082.00), less than 9 Meters Biopharma, Inc. (0), greater than Infinity Pharmaceuticals, Inc. (-37386946.00), less than Accelerate Diagnostics, Inc. (52.34M), greater than Bellicum Pharmaceuticals, Inc. (-21058674.00), less than Altamira Therapeutics Ltd. (392.64K), less than Timber Pharmaceuticals, Inc. (-7573217.00), less than CohBar, Inc. (-4738890.00), less than Neptune Wellness Solutions Inc. (23.36M), less than Acorda Therapeutics, Inc. (161.36M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -14406082.00 | $995.92K | |
| 0 | $1.45K | |
| -37386946.00 | $9.05K | |
| 52.34M | $859.92K | |
| -21058674.00 | $778.33K | |
| 392.64K | $1.13M | |
| -7573217.00 | $1.18M | |
| -4738890.00 | $1.19M | |
| 23.36M | $45.31K | |
| 161.36M | $821.03K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Impel Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Impel Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Impel Pharmaceuticals Inc.'s Enterprise Value?
What is the highest Enterprise Value for Impel Pharmaceuticals Inc. (IMPL)?
What is the 3-year average Enterprise Value for Impel Pharmaceuticals Inc. (IMPL)?
What is the 5-year average Enterprise Value for Impel Pharmaceuticals Inc. (IMPL)?
How does the current Enterprise Value for Impel Pharmaceuticals Inc. (IMPL) compare to its historical average?